Latest Ziccum News & Updates

See the latest news and media coverage for Ziccum. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Ziccum

Mass transfer drying technology for biologics

ziccum.com
Headquarters
Lund, Sweden
Founded year
2017
Company type
Private company
Number of employees
2–10

Last updated

Latest news about Ziccum

In short: Ziccum filed for bankruptcy at Lund District Court after failing to secure sufficient financing following an unsuccessful share issue.

Company announcements

  • Ziccum

    Ziccum AB applies for bankruptcy

    The board decides to apply at Lund District Court due to insufficient financing after failed emission and denied financing from GCF.

  • Ziccum

    Ziccum resolves directed share issue to GCF

    The board calls third investment tranche of 4,698,588 shares at SEK 0.47, raising SEK 2.2M amid financial challenges post disappointing rights issue. Dilution is 15.91%.

  • Ziccum

    Ziccum CEO participates in roundtable on vaccine innovation

    Ann Gidner addresses thermostable vaccines at Swedish Ministry event with Gavi CEO and ambassadors. LaminarPace draws interest; IVI plans visit.

  • Ziccum

    Ziccum presents at the Big Stock Days

    CEO Ann Gidner demonstrates LaminarPace technology that converts biological drugs into stable powders without cold chain. The presentation is available on YouTube.

Unlock all announcements with a

Media coverage

  • Dagens industri

    First North company Ziccum applies for bankruptcy

    Ziccum has decided on two new share issues, one of which is directed to Global Corporate Finance, GCF, and the other a rights issue. The directed new share issue amounts to...

  • FinanzNachrichten

    Ziccum AB: Ziccum AB (publ) Interim report Q3 2024

    Ziccum intends to resolve on a rights issue of approximately SEK 30 million and raises a bridge loan On October 10, The Board of Directors...

  • Dagens industri

    Ziccum: Data confirms air-drying technology in covid-19 vaccine

    Close Agenda: Quadruple witching and more interest rate decisions. Get an overview of the most important highlights ahead of Friday December 17 Ziccum, which develops new formulations of vaccines, confirms...

  • Life Science Sweden

    Göran Condradson leaves the CEO position at Ziccum

    My account Log in {{ truncateString(window.visitor.corporateClient.name, 12) }}{{ truncateString(window.visitor.corporateClient.name, 20) }} {{ truncateString ...

Unlock all articles with a

Never miss news about Ziccum

Track Ziccum and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.